Ischemic stroke due to antiphospholipid syndrome in a lupus patient: a case report
DOI:
https://doi.org/10.11606/issn.2176-7262.v53i3p327-331Keywords:
Stroke, Systemic Lupus Erythematosus, Antiphospholipid SyndromeAbstract
Systemic lupus erythematosus is an autoimmune disease that presents a wide spectrum of clinical manifestations caused by the chronic inflammatory state. Association with antiphospholipid antibody syndrome occurs in approximately
36% of lupus patients. In these patients, the underlying disease and the chronic use of corticosteroids contribute to accelerated atherosclerosis, a complication that adds increased cardiovascular risk. We report a case of stroke in a 25-year-old patient with systemic lupus erythematosus and antiphospholipid antibody syndrome.
Downloads
References
Johnson C, Nguyen M, Roth G, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology. 2019;18(5):439-458.
Yamamoto, FI. Ischemic stroke in young adults: an overview of etiological aspects. Arquivos de neuro-psiquiatria. 2012:70(6):462-466.
Hughes GR. V. Migraine, memory loss, and “multiple sclerosis”. Neurological features of the antiphospholipid (Hughes’) syndrome. Post grad Med J. 2003. Feb, 79 (928): 81-3.
Carvalho MAP. Bertolo MB, Lanna CCD. Reumatologia – Diagnóstico e Tratamento. Ed Guanabara Koogan, 2014. ISBN 6561141662.
Ricarte IF, Dutra LA. Manifestações neurológicas da síndrome do anticorpo antifosfolipídio. Ver Paul Reumatol. 2018 abr-jun; 17(2):12-7.
Smajlović D. Strokes in young adults: epidemiology and prevention. Vasc Health Risk Manag. 2015;11:157‐164.
Janssen AW, de Leeuw FE, Janssen MC. Risk factors for ischemic stroke and transient ischemic attack in patients under age 50. J Thromb Thrombolysis. 2011;31(1):85‐91. doi:10.1007/s11239-010-0491-3
Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012. 64: 2677.
Ferro JM, Massaro AR, Mas JL. Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol. 2010;9(11):1085‐1096.
Al-Saeed WM, Oleiwi Al-Kuraishi AH, Dahash SL, Al-Gareeb AI, Alkuraishy HM. Neurocysticercosis: A new concept and insight into basic and future pharmacotherapy. J Pak Med Assoc. 2019;69(Suppl 3)(8):S113‐S118.
Vidal JE. HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease. J Int Assoc Provid AIDS Care. 2019;18:2325958219867315.
Amorim L, Maia F, Rodrigues C. Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment. Lupus. 2017:26(5):529-536.
Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clinical Journal of the American Society of Nephrology. 2017:12(5):825-835.
Cavallaro M, Barbaro U, Caragliano A, Longo M, Cicero G, Granata F, et al. Stroke and Systemic Lupus Erithematosus: a review. EMJ Rheumatology. 2018:5(1):100-107.
Sanna G, D’Cruz D, Cuadrado MJ. Cerebral manifestations in the antiphospholipid (Hughes’) syndrome. Rheum Dis Cli North Am. 2006; 32(3): 465-90.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Thiago Azevedo de Lucena Costa, Leonardo Fernandes e Santana, Mateus de Sousa Rodrigues, Caroline Diniz Bezerra, Orlando Vieira Gomes, Rita Marina Soares de Castro Duarte
This work is licensed under a Creative Commons Attribution 4.0 International License.
